Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Amortization of Deferred Charges (2024 - 2025)

Envoy Medical's Amortization of Deferred Charges history spans 2 years, with the latest figure at $468000.0 for Q3 2025.

  • For Q3 2025, Amortization of Deferred Charges rose 77.27% year-over-year to $468000.0; the TTM value through Sep 2025 reached $2.0 million, changed N/A, while the annual FY2024 figure was $816000.0, N/A changed from the prior year.
  • Amortization of Deferred Charges for Q3 2025 was $468000.0 at Envoy Medical, down from $623000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $623000.0 in Q2 2025 and bottomed at $264000.0 in Q3 2024.